The JAK-STAT signaling pathway by LNK in hormone receptor-positive breast cancer and non-tumor cells

Regulation of the JAK-STAT signaling pathway by LNK in hormone receptor-positive breast cancer and non-tumor cells. Expression of IL-6R/gp130 and PRLR in non-tumor breast cells is closely associated with mammary gland development, whereas it is associated with cancer maintenance and initiation in hormone receptor-positive tumor cells. (1) Binding of IL-6 and PRL to their receptors induces activation of receptor-attached JAK2 kinases. (2) Active JAK2 phosphorylates STAT3 and STAT5 transcription factors. (3) STAT3 and STAT5 homodimers translocate into the nucleus and induce transcription of a number of genes that stimulate proliferation, differentiation, and survival of mammary cells. (4) STAT3 and STAT5 also stimulate the expression of LNK. (5) LNK localizes to the inner side of the cell membrane via interaction of the PH domain with membrane phosphatidylinositol lipids. This allows binding of the SH2 domain to JAK2, inhibiting the cascade. In tumor cells, constitutive activation of the IL6-IL-6R/JAK2-STAT3 and PRL-PRLR/JAK2-STAT5 loops may be associated with dysfunction of LNK. Three potential mechanisms have been proposed: (6) a reduction in LNK expression; (7) a blockage of LNK activity by binding with the inhibitor molecule 14-3-3; and (8) the presence of the SH2B3 missense variant rs3184504 (yellow star), which may be unable to interact with the cell membrane. As a result, increased proliferation, survival, migration, invasion capacity, and resistance to endocrine treatment have been reported. IL-6: interleukin-6; IL-6R/gp130: interleukin-6 receptor/glycoprotein 130; PRL: prolactin; PRLR: prolactin receptor; JAK2: Janus kinase 2; STAT3: signal transducer and activator of transcription 3; STAT5 signal transducer and activator of transcription 5; LNK: lymphocyte adaptor protein; PH: pleckstrin homology domain; SH2: Src homology 2 domain; DD: dimerization domain; pS13: phosphoserine 13; pS129: phosphoserine 129. Figure created with BioRender.com.
The JAK-STAT signaling pathway by LNK in hormone receptor-positive breast cancer and non-tumor cells

Publication

Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer (2023) José A. López-Mejía, et al. Int J Mol Sci. 2023 Oct;24(19):14777. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates IL-6R- IL6R ncbigene_symbol IL6R 3570
Homo sapiens Primates IL-6 IL-6 ncbigene_synonym IL6 3569
Homo sapiens Primates JAK2 JAK2 ncbigene_symbol JAK2 3717
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates LNK LNK ncbigene_synonym SH2B3 10019
Homo sapiens Primates PRLR PRLR ncbigene_symbol PRLR 5618
Homo sapiens Primates PRLR PRLR ncbigene_synonym PTP4A3 11156
Homo sapiens Primates PRL PRL ncbigene_symbol PRL 5617
Homo sapiens Primates STAT5 STAT5 ncbigene_synonym STAT5A 6776
Homo sapiens Primates STAT5 STAT5 ncbigene_synonym STAT5B 6777
Homo sapiens Primates Bcl-XL,Bcl-2 BCL-2 ncbigene_synonym BCL2 596
Homo sapiens Primates Bcl-XL,Bcl-2 BC2 ncbigene_synonym CHMP2A 27243
Homo sapiens Primates c-Myc C-MYC ncbigene_synonym MYC 4609
Homo sapiens Primates cyclinD1 CCND1 ncbigene_symbol CCND1 595
Homo sapiens Primates MMP-1 MMP1 ncbigene_symbol MMP1 4312
Homo sapiens Primates MMP-1/2/3/9 MMP-2 ncbigene_synonym MMP2 4313
Homo sapiens Primates MMP-1/2/3/9 MMP-9 ncbigene_synonym MMP9 4318
Homo sapiens Primates MMP-1/2/3/9 MMP-3 ncbigene_synonym MMP3 4314
Homo sapiens Primates Pim-1 PIM1 ncbigene_symbol PIM1 5292
Homo sapiens Primates Pim-1 PIM1 ncbigene_synonym LONP1 9361
Homo sapiens Primates 14-3-3 14-3-3 ncbigene_synonym YWHAQ 10971

Chemical mentions

Word Match MeSH Name ChEBI
PRL PRL chebi:81580

Disease mentions

Word Match MeSH Name DOID
Cancer cancer cancer DOID:162
Cancer cancer cancer DOID:162